What is the future of extending longevity and healthspan? In this compelling talk at NextMed Health (http://NextMed.Health), stem cell and regenerative medicine pioneer Hans Keirstead PhD shares an overview of the field and the latest in approaches, including leveraging the stem cell 'secretome' to enable immunomodulation to address elements of ageing.

Dr. Keirstead is the founder and chairman of Immunis Inc., a biotech company creating novel cellular secretome therapies for age and disease-related immune decline. http://ImmunisBiomedical.com.

NextMed Health is a unique program and community exploring and catalyzing the future of health and biomedicine. Learn more and join us at http://NextMed.Health/join